openPR Logo
Press release

Anterior Uveitis Market to Perceive Substantial Growth by 2024

03-13-2018 01:38 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anterior Uveitis Market to Perceive Substantial Growth by 2024

Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition of the eye and also to reduce glare of the light that enters by absorbing the light and reducing internal reflection within the eye. In addition the uvea also helps in generating the aqueous humour and in controlling the focus of the eye lens. The uvea also consists of lymphocytes and is therefore prone to respond to inflammation by developing lymphocytic infiltrates. Uveitis is therefore a condition that requires urgent response from an ophthalmologist and immediate treatment.

Anterior Uveitis mainly includes iritis, which is known as the inflammation of the anterior chamber and the iris, and iridocyclitis, which is inflammation of the iris anterior chamber and the vitreous cavity. Anterior uveitis presents itself as redness of the eyes, irregular pupils, photophobia, blurred vision, eye pain/pressure, floaters visible to the patient, headaches, iridocyclitis induced cataract/glaucoma or synechia (attachment of iris to cornea or lens). The causative factors for uveitis has not yet been confirmed, however in half of the anterior uveitis cases a correlation was observed with the presence of HLA-B27 gene, which is a type of human leukocyte antigen (HLA) that increases the probability of an individual to contract uveitis by 15%.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2956

Anterior uveitis or acute anterior uveitis is the most common form of uveitis. Uveitis is primarily found to be systemic immune based; however possible causative factors in many cases also include infections from: Brucellosis, Leptospirosis, Lyme disease, Tuberculosis, Syphilis, Toxoplasmic chorioretinitis, Toxocariasis, or ocular histoplasmosis syndrome. Besides these drug interactions like rifabutin can also cause uveitis. Basically Uveitis occurs from the failed or hyperactive ocular immune response, this results in tissue destruction and inflammation, followed by buildup of mucus in extreme cases, hence the increased pressure.

The treatment for uveitis is mainly symptom specific, with steroids and non-steroidal anti inflammatory drugs ins the form of eye drops, or oral medications. Corneal ulcers if present may pose as complications hence anti-inflammatory medication is prescribed only after ruling out this disorder. Cyclopegics or ciliary muscle relaxants are administered for diagnosis or certain surgical treatment if necessary. Anti TNF agents and other anti metabolite medications may prove helpful in cases of severe uveitis, e.g. infliximab.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2956

Certain drugs like metformin, which is generally used as anti-diabetic drug has also been found to reduce inflammation in uveitis. Recent drugs like gevokizumab have undergone trials to for uveitis without infectious origin. The treatments given vary with the causative factor of uveitis, but overall the condition usually recedes after proper care and procedures are followed. In severe adverse cases, vision loss or cataract/glaucoma may occur, such cases however occur in very rare occasions. The incidence rate is as high as one in 4500 individuals globally according to a medical journal on ocular immunology. The incidence rates in developed countries of the west are higher than the developing countries in Asia and Africa. The anterior uveitis market is therefore restricted to North American and European region, followed by Asia, South America and Rest of the World.

Some of the companies involved in the production of uveitis related drugs include: Novartis AG, Amdipharm Mercury Company Limited, Santen pharmaceuticals, etc.

View Report -

https://www.transparencymarketresearch.com/anterior-uveitis-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anterior Uveitis Market to Perceive Substantial Growth by 2024 here

News-ID: 976750 • Views: 157

More Releases from Transparency Market Research

Lyocell Fibers Market is anticipated to expand at a CAGR of ~12% from 2019 to 20 …
Lyocell Fibers Market: Key Highlights The global lyocell fibers market was valued at ~US$ 818 Mn in 2018, and is anticipated to expand at a CAGR of ~12% from 2019 to 2027. The global lyocell fibers market is driven by the growth of the apparel industry. In terms of value, the lyocell fibers market in Asia Pacific is expected to expand at a high CAGR during the forecast period. China held a major
Small Hydropower Market is expected to expand at a CAGR of 2.9% during the forec …
Highlights of Small Hydropower Market The global small hydropower market is expected to expand at a CAGR of 2.9% during the forecast period. In terms of installed capacity, the small hydropower market is projected to develop installed capacity as high as 160.13 GW by end of 2027, growing from a net capacity of 124.06 GW in 2018. Read report Overview- https://www.transparencymarketresearch.com/small-hydropower-market.html The domain of renewable energy production ensembles a robust framework for global and
Solar Thermal Fuel Market Evolving Technology, Trends and Industry Analysis : 20 …
Solar Thermal Fuel Market: A practical green energy source Solar thermal fuel is a chemical that can absorb solar radiation, store it for a longer period, and release it. Solar thermal fuels (STFs) store solar energy through light-induced changes in their molecular structure, and release the energy in the form of heat in future, as needed. Read report Overview- https://www.transparencymarketresearch.com/solar-thermal-fuel-market.html Solar thermal fuel works on the principle of artificial photosynthesis. It absorbs sunlight and
Automotive Suspension Parts Market Comprehensive Analysis By 2030
Automotive Suspension Parts Market: Introduction According to the report, the global automotive suspension parts market is projected to surpass ~US$ 13 Bn by 2030, expanding at a CAGR of ~3%, owing to an increase in affordability for vehicles among consumers and transition of people into middle and upper middle income groups. The global automotive suspension parts market is mature; however, developments on improving performance of shock absorbers are still boosting

All 5 Releases


More Releases for Uveitis

Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and
Global Uveitis market Research Report - Pipeline Review, H2 2017
"The Latest Research Report Uveitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Uveitis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis-Pipeline Review, H2 2017, provides an overview of the Uveitis (Ophthalmology) pipeline landscape. Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis
Uveitis Treatment Market Worth US$ 847.8 Mn by 2024-End
The US$ 497 Mn uveitis treatment market is likely to expand at a stable CAGR of 6.5% over the next eight years. In 2017, the market is expected to witness nearly 6.7% Y-o-Y growth over 2016. During 2016-2024, Persistence Market Research predicts a positive growth outlook for the global uveitis treatment market, influenced by several growth drivers, restraints, trends, and opportunities. In its recently published report titled “Uveitis Treatment Market: Industry